Latest News and Press Releases

LeonaBio, Inc. (NASDAQ: LONA), announced the appointment of Fred Callori, J.D., Natalie Holles, and Peter Silverman, J.D. to its Board of Directors.

MELBOURNE, Australia and SAN FRANCISCO, May 07, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing...

Trethera to present optic neuritis research, highlighting TRE-515, a first-in-class oral inhibitor of dCK, advancing a novel autoimmune disease treatment.

MMI today announced completion of the first robotic-assisted procedure in REMIND, its U.S. Investigational Device Exemption (IDE) Study

Highlights Aligned with the FDA in two Positive Type C meetings supporting key elements of the planned Phase 3 program for ATH434 in MSAAdvancing ATH434 toward pivotal Phase 3 program; on track for...

Freiburg, Germany, April 29, 2026 (GLOBE NEWSWIRE) -- CorTec GmbH today announced that the first participant in the University of Washington’s NIH-funded clinical trial of the Brain Interchange™...

 – Alignment reached on chemistry, manufacturing, and control (CMC) elements of ATH434 Phase 3 development program – – Positive feedback supports readiness for Phase 3 initiation with manufacturing...

Neura Health to expand access to migraine care via LillyDirect, with appointments available within seven days

- ATH434 reduced functional decline vs placebo at Week 52 on MuSyCA, a newly described MSA composite scale - - Effects seen on both daily function and neurological examination, consistent with...

Austin, TX, USA, April 21, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Surgical Drill Bits Market Size, Trends and Insights By Type (Standard Solid...